The U.S. ambulatory surgery center market size is expected to reach USD 60.8 billion registering a CAGR of 6.00% during the forecast period. The report projects that the U.S. ambulatory surgery center devices market size will reach USD 49.1 billion by 2030, growing at a CAGR of 9.16% during the forecast period. The market is highly fragmented and is expected to witness high competition in the coming years. The centers mainly face competition from HOPDs and new ASCs opening every year. For instance, according to Becker’s ASC Review, around 258 new ASCs were opened in the U.S. in 2021.
Ambulatory surgery centers (ASCs) have also undergone significant technological advancements in recent years, with a focus on improving patient outcomes, reducing costs, and enhancing operational efficiency. For instance, the growing use of robotics and 3D printing technology has enabled surgeons to perform more precise and less invasive procedures, resulting in faster recovery times and better patient outcomes. For instance, in July 2020, the Southeastern Spine Institute (SSI) Ambulatory Surgery Center, which is affiliated with United Surgical Partners International (USPI), introduced a new program for robotic-assisted surgery.
The COVID-19 pandemic has significantly impacted the U.S. ASCs market during the initial period, owing to the postponement of nonurgent surgeries and the decline in patient volumes due to stringent guidelines. Post-pandemic patients are shifting from hospital to outpatient settings to treat various disease conditions, contributing to market growth. Moreover, hospitals are shifting toward acquiring ASCs post-pandemic owing to the shift in patient preference for ASCs due to the fear of exposure to COVID-19 in hospitals. For instance, in November 2021, Tenet Healthcare Corporation and United Surgical Partners International (USPI), its subsidiary, entered into a definitive agreement to acquire 92 ASCs owned by SurgCenter Development (SCD).
This product will be delivered within 1-3 business days.
Ambulatory surgery centers (ASCs) have also undergone significant technological advancements in recent years, with a focus on improving patient outcomes, reducing costs, and enhancing operational efficiency. For instance, the growing use of robotics and 3D printing technology has enabled surgeons to perform more precise and less invasive procedures, resulting in faster recovery times and better patient outcomes. For instance, in July 2020, the Southeastern Spine Institute (SSI) Ambulatory Surgery Center, which is affiliated with United Surgical Partners International (USPI), introduced a new program for robotic-assisted surgery.
The COVID-19 pandemic has significantly impacted the U.S. ASCs market during the initial period, owing to the postponement of nonurgent surgeries and the decline in patient volumes due to stringent guidelines. Post-pandemic patients are shifting from hospital to outpatient settings to treat various disease conditions, contributing to market growth. Moreover, hospitals are shifting toward acquiring ASCs post-pandemic owing to the shift in patient preference for ASCs due to the fear of exposure to COVID-19 in hospitals. For instance, in November 2021, Tenet Healthcare Corporation and United Surgical Partners International (USPI), its subsidiary, entered into a definitive agreement to acquire 92 ASCs owned by SurgCenter Development (SCD).
U.S. Ambulatory Surgery Center Market Report Highlights
- Based on specialty, the orthopedics segment held the largest revenue share in 2022 due to the addition of new procedures under ASC coverage. Also, improving diagnostic methods & imaging technologies in orthopedic surgeries is also contributing to the growth
- Based on ownership, the physician-owned segment is anticipated to witness significant growth over the forecast period owing to advantages associated with it such as the presence of skilled physicians and their easy availability
- Based on center type, the single-specialty segment held the largest revenue share of the U.S. market for ambulatory surgical centers in 2022. Single-specialty ASCs are designed to provide a more personalized and efficient patient experience
- Based on device type, the orthopedic segment held a significant revenue share in 2022, owing to the increasing incidence of injuries and trauma-imposing surgical procedures
- Based on region, the Southeast region dominated the market in 2022. The region is highly competitive, with many providers competing for a share of the outpatient surgical market
- Companies are increasingly favoring ASCs as a treatment option, and many medical device manufacturers are collaborating with ASCs to strengthen their business portfolio. For instance, in July 2020, the Southeastern Spine Institute (SSI) Ambulatory Surgery Center, which is affiliated with United Surgical Partners International (USPI), introduced a new program for robotic-assisted surgery
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Report Scope & Research Methodology
Chapter 2 Research Objectives
Chapter 3 Executive Summary
Chapter 4 U.S. Ambulatory Surgery Center Market - Industry Outlook
Chapter 5 U.S. Ambulatory Surgery Center Market: Specialty Estimates & Trend Analysis
Chapter 6 U.S. Ambulatory Surgery Center Market: Ownership Estimates & Trend Analysis
Chapter 7 U.S. Ambulatory Surgery Center Market: Center Type Estimates & Trend Analysis
Chapter 8 U.S. Ambulatory Surgery Center Device Market: Device Type Estimates & Trend Analysis
Chapter 9 U.S. Ambulatory Surgery Center Market: Regional Estimates & Trend Analysis
Chapter 10 U.S. Ambulatory Surgery Center Market Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Envision Healthcare Corporation
- Tenet Healthcare Corporation
- Mednax Services, Inc.
- TeamHealth
- UnitedHealth Group
- Quorum Health
- Surgery Partners
- Community Health Systems, Inc.
- SurgCenter
- Prospect Medical Systems
- Edward-Elmhurst Health
- MCKESSON CORPORATION
- BD
- Koninklijke Philips N.V.
- 3M
- Olympus America
- GE HealthCare
- Abbott
- Medtronic
- Zimmer Biomet
- Henry Schein, Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 101 |
Published | October 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 36.8 Billion |
Forecasted Market Value ( USD | $ 60.8 Billion |
Compound Annual Growth Rate | 6.0% |
Regions Covered | United States |
No. of Companies Mentioned | 21 |